Argos Therapeutics (FRA:77AA) Accounts Payable & Accrued Expense : €2.44 Mil (As of Sep. 2018)

View and export this data going back to 2014. Start your Free Trial

What is Argos Therapeutics Accounts Payable & Accrued Expense?

Argos Therapeutics's quarterly accounts payable & accrued expense declined from Mar. 2018 (€3.18 Mil) to Jun. 2018 (€2.30 Mil) but then increased from Jun. 2018 (€2.30 Mil) to Sep. 2018 (€2.44 Mil).

Argos Therapeutics's annual accounts payable & accrued expense increased from Dec. 2015 (€6.05 Mil) to Dec. 2016 (€14.56 Mil) but then declined from Dec. 2016 (€14.56 Mil) to Dec. 2017 (€1.89 Mil).

Argos Therapeutics Accounts Payable & Accrued Expense Historical Data

The historical data trend for Argos Therapeutics's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Argos Therapeutics Accounts Payable & Accrued Expense Chart

Argos Therapeutics Annual Data

Trend

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

2.28

2.65

6.05

14.56

1.89

Argos Therapeutics Quarterly Data
	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															6.10	1.89	3.18	2.30	2.44

Argos Therapeutics Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Argos Therapeutics (FRA:77AA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Argos Therapeutics Inc (FRA:77AA) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

4233 Technology Drive, Durham, NC, USA, 27704

Website

http://www.argostherapeutics.com

Argos Therapeutics Inc is a biopharmaceutical company. It is engaged in the development and commercialization of immunotherapies for the treatment of cancer and infectious diseases based on its proprietary technology platform called Arcelis.

Argos Therapeutics (FRA:77AA) Headlines

No Headlines